[go: up one dir, main page]

AU3324000A - Use of niaouli essential oil as transdermal permeation enhancer - Google Patents

Use of niaouli essential oil as transdermal permeation enhancer

Info

Publication number
AU3324000A
AU3324000A AU33240/00A AU3324000A AU3324000A AU 3324000 A AU3324000 A AU 3324000A AU 33240/00 A AU33240/00 A AU 33240/00A AU 3324000 A AU3324000 A AU 3324000A AU 3324000 A AU3324000 A AU 3324000A
Authority
AU
Australia
Prior art keywords
essential oil
permeation enhancer
transdermal permeation
niaouli essential
niaouli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33240/00A
Inventor
Pietro Bianchini
Enrico Boldrini
Boris Giannaccini
Daniela Monti
Marco Fabrizio Saettone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmigea SpA
Original Assignee
Farmigea SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmigea SpA filed Critical Farmigea SpA
Publication of AU3324000A publication Critical patent/AU3324000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU33240/00A 1999-03-10 2000-03-09 Use of niaouli essential oil as transdermal permeation enhancer Abandoned AU3324000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM99A0151 1999-03-10
IT1999RM000151A IT1305303B1 (en) 1999-03-10 1999-03-10 USE OF NIAOULI ESSENTIAL OIL AS A PROMOTER FOR TRANSDERMAL PERMEAZION.
PCT/IT2000/000079 WO2000053228A2 (en) 1999-03-10 2000-03-09 Use of niaouli essential oil as transdermal permeation enhancer

Publications (1)

Publication Number Publication Date
AU3324000A true AU3324000A (en) 2000-09-28

Family

ID=11406548

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33240/00A Abandoned AU3324000A (en) 1999-03-10 2000-03-09 Use of niaouli essential oil as transdermal permeation enhancer

Country Status (4)

Country Link
EP (1) EP1159009A2 (en)
AU (1) AU3324000A (en)
IT (1) IT1305303B1 (en)
WO (1) WO2000053228A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
DE10053383A1 (en) * 2000-10-27 2002-05-08 Bionorica Arzneimittel Gmbh Use of terpenes as enhancers of transmucosal absorption and pharmaceutical preparations containing terpenes
DE10056011A1 (en) * 2000-11-11 2002-05-16 Beiersdorf Ag Well tolerated plaster for controlled delivery of essential oils to skin or air, has active agent containing matrix comprising polyisobutylene, amorphous poly-alpha-olefin and optionally filler
ITMI20041855A1 (en) * 2004-09-29 2004-12-29 Polichem Sa PHARMACEUTICAL COMPOSITIONS OF ALFA-DIHYDROERGOCRIPTINE FOR TRANSDERMAL AND-OR TRANSMUCOUS USE.
MX2010013946A (en) * 2008-06-24 2011-02-15 Intervet Int Bv PHARMACEUTICAL TRANSDERMIC COMPOSITIONS AND METHOD TO TREAT INFLAMMATION IN WON
MX2016016469A (en) 2014-06-30 2017-04-10 Koninklijke Philips Nv Sample holder for biological samples.
US10232048B1 (en) * 2014-11-18 2019-03-19 Divine Api-Logics, LLC Apitherapy method and composition
EP3723729B8 (en) * 2017-12-11 2023-11-01 Meat & Livestock Australia Limited Transdermal analgesic formulation
PL443690A1 (en) * 2023-02-05 2024-08-12 Rodakowska Ewelina Composition of plant-derived compounds, method of its preparation and use for medicinal purposes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0609330A1 (en) * 1991-10-26 1994-08-10 FLOCKHART, Ian Composition for topical application
DE19518836C2 (en) * 1995-05-23 1997-05-22 Gisela Hartwig Medicines or medicines, in particular for the prevention and treatment of pressure ulcers
IT1297080B1 (en) * 1997-11-26 1999-08-03 Andrea Carnevali COMPOSITION FOR THE TREATMENT OF BURNS, SOLAR erythema, ABRASIONS, SAGS AND SKIN IRRITATIONS

Also Published As

Publication number Publication date
WO2000053228A3 (en) 2000-11-16
IT1305303B1 (en) 2001-05-04
EP1159009A2 (en) 2001-12-05
WO2000053228A2 (en) 2000-09-14
ITRM990151A1 (en) 2000-09-10

Similar Documents

Publication Publication Date Title
AU763356C (en) Fused-ring compounds and use thereof as drugs
AU7389300A (en) Methods of administration of glycopyrrolate compositions
AU1585601A (en) Transdermal administration of huperzine
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
AU7490200A (en) New and improved formulation for paclitaxel
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU4137400A (en) Heterocyclic derivatives useful as anticancer agents
AU4343500A (en) Use of azetidinone compounds
AU4458700A (en) Uses of phenylglycine derivatives
AU5326100A (en) Pharmaceutical compositions and methods for use
AU1887401A (en) Medicinal composition
AU2220801A (en) Tricyclic compounds and addition salts thereof
AU3324000A (en) Use of niaouli essential oil as transdermal permeation enhancer
AU5460800A (en) Pharmaceutical transdermal compositions
AU3869399A (en) Transdermal administration of fenoldopam
AU1068101A (en) Transdermal administration of reboxetine
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU2003207450A1 (en) Enhanced liposomal thioretinaco ozonide compositions and liposomal carrier
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU4614100A (en) Cyanobiphenyl derivatives
AU2001294257A1 (en) Method of purifying pravastatin or its pharmacologically acceptable salt
AU4917000A (en) Oligohydroxyl substituted benzofuran-3-yl and pyridofuranylurea derivatives as phosphodiesterase iv inhibitors
AU1226001A (en) Phospholipids of hydroxyeicosatetraenoic acid-like derivatives
AU7711800A (en) Novel uses of 2-bromopalmitate

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase